Molecular Mechanism of Enhanced Anticancer Effect of Nanoparticle Formulated LY2835219 via p16-CDK4/6-pRb Pathway in Colorectal Carcinoma Cell Line

Table 1

Characterization of LY2835219-loaded nanoparticles (mean ± SD, ).

Formulation	LE (%)	EE (%)	Particle size (nm)	Zeta potential (mV)
CNP/LY	21.3 ± 5.2	41.7 ± 7.1	195 ± 39.6	37.3 ± 1.5
HACNP/LY	24.1 ± 3.5	36.9 ± 6.2	217 ± 31.1	30.3 ± 2.2